VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 59 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,799,762 | -30.7% | 443,270 | -7.3% | 0.58% | -32.4% |
| Q3 2022 | $9,811,717 | +90.3% | 478,387 | +7.4% | 0.85% | +131.6% |
| Q2 2022 | $5,155,499 | +79.0% | 445,592 | +186.1% | 0.37% | +66.1% |
| Q1 2022 | $2,879,688 | -25.1% | 155,743 | -20.0% | 0.22% | -10.2% |
| Q4 2021 | $3,847,025 | +46.2% | 194,589 | +21.6% | 0.25% | +34.4% |
| Q3 2021 | $2,632,000 | – | 160,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |